Biofrontera AG Sponsored ADR Depreciation & Amortization Growth

Depreciation & Amortization Growth of BFAGY for past 10 years: annual, quarterly and twelve month trailing (TTM) including Depreciation & Amortization Growth growth rates and interactive chart.


Highlights and Quick Summary

  • Depreciation & Amortization Growth for the quarter ending June 30, 2021 was 726.19% (a 100.35% increase compared to previous quarter)
  • Year-over-year quarterly Depreciation & Amortization Growth decreased by -1026.5%
  • Annual Depreciation & Amortization Growth for 2021 was -4.17% (a -87.49% decrease from previous year)
  • Annual Depreciation & Amortization Growth for 2021 was -33.33% (a -2107.83% decrease from previous year)
  • Annual Depreciation & Amortization Growth for 2020 was 1.66% (a -97.61% decrease from previous year)
Visit stockrow.com/BFAGY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Depreciation & Amortization Growth of Biofrontera AG Sponsored ADR

Most recent Depreciation & Amortization Growthof BFAGY including historical data for past 10 years.

Interactive Chart of Depreciation & Amortization Growth of Biofrontera AG Sponsored ADR

Biofrontera AG Sponsored ADR Depreciation & Amortization Growth for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 726.19% -4.17%
2020 362.46% 1.66%
2019 -2.56%
2018 -1.97%
2017 -87.9% 7.38%
2016 -78.38% 1.83%

Business Profile of Biofrontera AG Sponsored ADR

Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic